Pyxus Announces Transaction Support Agreement with a Majority of Creditors for Exchange Transactions and Equity Offering
Full participation would convert approximately $92 million of debt into equity and fund a $65 million debt paydown with offering proceeds.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Pyxus International (PYYX) signed a transaction support agreement with majority creditors for proposed debt exchanges and an equity offering. If completed in full, the exchanges would convert approximately $92 million of debt into equity, repay $65 million using offering proceeds and extend maturities on approximately $300 million of remaining debt.
The private equity offering would raise up to $85 million at $2.50 per share. Existing notes and Pyxus term loans would be exchanged for new secured notes and stock valued at $3.25 per share; Intabex lenders would receive new secured notes and cash. The exchanges have not commenced, and terms remain subject to change. Completion requires definitive documents, necessary consents, including revolving-credit lender consent, and minimum participation thresholds. Pyxus expects completion by December 15, 2026, unless extended by agreement.
How this balance works
Rhea-AI gives every point it takes from this document a weight. Minor counts 1, Moderate 3 and Major 9, so one Major point outweighs several Minor ones. The bar adds up the weights on each side, and when neither side holds more than 65% of the total the balance reads Mixed.
It reads the document as published, with the same rules for every company, and it does not look at what the market expected or at how the stock traded, so a point can be objectively good on a day the stock falls.
Rhea-AI Sentiment measures something else, the tone of the wording.
Hollow bars mark forward-looking points. How the balance works
Positive
- Moderate point. Forward-looking: it has not happened yet and may not happen.Full completion would convert approximately $92 million of debt into equity, reducing outstanding debt. 1.6× market cap
- Moderate point. Forward-looking: it has not happened yet and may not happen.Private equity offering would raise up to $85 million in new capital. 1.5× market cap
- Moderate pointSupporting creditors hold approximately 67.9% of Intabex loans, 74.9% of Pyxus loans and 56.0% of existing notes.
- Minor point. Forward-looking: it has not happened yet and may not happen.Offering proceeds would fund a $65 million debt paydown if exchanges are completed in full.
- Minor point. Forward-looking: it has not happened yet and may not happen.Full completion would extend maturities on approximately $300 million of remaining debt.
2 minor points
- Minor point. Forward-looking: it has not happened yet and may not happen.Backstop parties committed to purchase $42.5 million directly and backstop another $37.5 million, subject to terms.
- Minor point. Forward-looking: it has not happened yet and may not happen.Proposed debt-document amendments would eliminate most restrictive covenants and certain affirmative covenants.
Negative
- Moderate point. Forward-looking: it has not happened yet and may not happen.Equity offering at $2.50 per share would issue new common stock, diluting existing shareholders.
- Moderate point. Forward-looking: it has not happened yet and may not happen.Notes and Pyxus loan exchanges would issue $344.37 of stock at $3.25 per share per $1,000 principal, diluting holders.
- Minor point. Forward-looking: it has not happened yet and may not happen.Exchange consideration retains secured debt: $675.90 per $1,000 of notes or Pyxus loans; $679.41 for Intabex loans.
- Minor point. Forward-looking: it has not happened yet and may not happen.Backstop premiums and early signing payments would be paid in additional shares at $2.50 per share.
- Minor point. Forward-looking: it has not happened yet and may not happen.Offering proceeds would also pay transaction fees and expenses.
3 minor points
- Minor pointExchange terms remain subject to change; the transactions have not commenced.
- Minor pointCompletion requires definitive documentation, necessary consents and minimum participation thresholds for each existing debt category.
- Minor pointEquity offering completion depends on substantially concurrent completion of the exchanges.
AI-generated analysis. How Rhea-AI works. Not financial advice.
The transactions will meaningfully reduce outstanding debt, extend maturities, provide additional financial flexibility and support long-term growth
The Supporting Holders hold approximately (i)
Pursuant to the Transaction Support Agreement, the Company and its subsidiaries intend to commence comprehensive exchange transactions offered to all qualified holders of its Existing Secured Debt, by which such holders will be offered the opportunity to exchange or sell all of their Existing Secured Debt for newly issued secured debt and, with respect to holders of Pyxus Term Loans and Existing Notes, newly issued common stock (the "Exchange Transactions"). If consummated in full, the Exchange Transactions will result in converting approximately
More specifically, the Exchange Transactions will include, among other things:
- Eligible holders of the Existing Notes to be offered the opportunity to exchange any and all of their Existing Notes, pursuant to an exchange offer to be conducted by Pyxus Holdings and the Company (the "Notes Exchange Offer"), for (i)
$344.37 $3.25 $675.90 $1,000 - In conjunction with, and upon commencement of, the Notes Exchange Offer, the Company intends to solicit consents from holders of the Existing Notes to amend the indenture governing the Existing Notes (the "Existing Notes Indenture") and the related intercreditor and security documents as necessary to, among other things, (i) eliminate most of the restrictive covenants and certain of the affirmative covenants in the Existing Notes Indenture; (ii) eliminate the change of control repurchase obligation in the Existing Notes Indenture; (iii) subordinate the Existing Notes in right of payment to existing and future senior indebtedness (including the Exchange Notes); (iv) eliminate certain events of default; and (v) release all of the collateral securing the Existing Notes;
- Each holder of the Pyxus Term Loans to be offered the opportunity to exchange or sell all of its Pyxus Term Loans for (i)
$344.37 $675.90 $1,000 - Each holder of the Intabex Term Loans to be offered the opportunity to exchange or sell all of its Intabex Term Loans in open market purchases for
$679.41 $344.37 $1,000 - In conjunction with, and upon commencement of, the Pyxus Term Loan Exchange Offer and the Intabex Term Loan Exchange Offer, the Company intends to solicit consents from holders of the existing Pyxus Term Loans and Intabex Term Loans to amend the credit agreements governing the Pyxus Term Loans and the Intabex Term Loans (the "Pyxus Credit Agreement" and the "Intabex Credit Agreement," respectively) and the related intercreditor and security documents as necessary to, among other things, (i) eliminate most of the restrictive covenants and certain of the affirmative covenants in the Pyxus Credit Agreement and the Intabex Credit Agreement; (ii) consent to the Exchange Transactions and Equity Offering; (iii) subordinate the Pyxus Term Loans and Intabex Term Loans in right of payment and the guarantees thereof to the Exchange Notes; and (iv) waive or eliminate certain defaults and events of default, if any.
The Exchange Transactions have not yet commenced. The terms described above remain subject to change and will be set forth in the definitive offering documents distributed to eligible holders upon commencement. Pursuant to the Transaction Support Agreement, the Company and its subsidiaries have agreed to commence the Notes Exchange Offer no later than ten days after the effective date of the Transaction Support Agreement, and to commence the Pyxus Term Loan Exchange Offer, the Intabex Term Loan Exchange Offer and the Equity Offering (as defined below) as promptly as reasonably practicable thereafter.
Holders that validly participate in the Exchange Transactions within ten business days after the launch thereof will receive the consideration described above. Holders that participate thereafter will receive
Pursuant to the Transaction Support Agreement, the Company has agreed to offer qualified holders of the Existing Notes, the Pyxus Term Loans and the Intabex Term Loans (including the Supporting Holders) the opportunity to participate, following commencement of the Exchange Transactions, in a private offering (the "Equity Offering") of up to
On November 5, 2026, certain of the Supporting Holders (in such capacity, the "Backstop Parties") entered into a backstop purchase agreement, dated as of the date of the Transaction Support Agreement, pursuant to which the Backstop Parties have committed, subject to the terms and conditions set forth therein, to backstop a portion of the Equity Offering. In consideration for such commitment, the Backstop Parties will receive, on the closing date of the Exchange Transactions, a premium payable in shares of Common Stock at the Subscription Price. In addition, the Company has agreed to pay, on the closing date of the Exchange Transactions, an early signing payment to the members of the ad hoc group of Supporting Holders that executed the Transaction Support Agreement on or prior to its effective date, payable in shares of Common Stock at the Subscription Price, subject to the terms and conditions of the Transaction Support Agreement and the backstop purchase agreement.
In conjunction with the Exchange Transactions, the Company has agreed to use its commercially reasonable efforts to implement and consummate the Exchange Transactions and Equity Offering, and the Supporting Holders have agreed to, among other things, exchange their Existing Secured Debt in the Exchange Transactions, provide consents in the consent solicitations and under certain existing documents governing the Existing Secured Debt, and, in the case of the Backstop Parties, backstop the Equity Offering.
"Entering into this agreement represents an important step in our efforts to strengthen Pyxus' capital structure, extend key debt maturities and enhance the Company's financial flexibility as we continue to advance our strategic priorities," said Pyxus President and CEO Pieter Sikkel. "We appreciate the engagement and support we have received from lenders and noteholders as this process moves forward and believe these transactions will strengthen Pyxus' foundation for long-term success, support strategic execution and enhance stakeholder value."
The Transaction Support Agreement, Equity Offering and Exchange Transactions described above were recommended by a special committee of the Board of Directors of the Company comprising a majority of the disinterested members and approved by the Board of Directors of the Company.
The transactions contemplated by the Transaction Support Agreement are subject to certain conditions, including execution and delivery of definitive documentation, receipt of all necessary consents, including the consent of the requisite lenders under the credit agreement governing the Company's asset-based revolving credit facility (the "ABL Credit Agreement"), the satisfaction of minimum participation thresholds with respect to each of the Intabex Term Loans, the Pyxus Term Loans and the Existing Notes, and other customary closing conditions. The Company expects to commence the Notes Exchange Offer no later than ten days after the effective date of the Transaction Support Agreement, and the Pyxus Term Loan Exchange Offer, the Intabex Term Loan Exchange Offer and the Equity Offering promptly thereafter, and expects that the transactions will be completed on or prior to December 15, 2026, unless extended as otherwise agreed by the Company and the requisite Supporting Holders.
Simpson Thacher & Bartlett LLP and Robinson, Bradshaw & Hinson, P.A. are serving as legal advisors to the Company, and Moelis & Company LLC is serving as exclusive financial advisor and investment banker to the Company. Paul Hastings LLP is serving as legal advisor to the Supporting Holders.
Any questions regarding the transactions described above may be directed to the Company's investor relations team at https://investors.pyxus.com/investors/overview/default.aspx.
About Pyxus International, Inc.
Pyxus International, Inc. is a global agricultural company with more than 150 years of experience delivering value-added products and services to businesses and customers. Driven by a united purpose—to transform people's lives, so that together we can grow a better world—Pyxus International, its subsidiaries and affiliates, are trusted providers of responsibly sourced, independently verified, sustainable and traceable products and ingredients.
Disclaimer
This press release is for informational purposes only and does not constitute an offer to sell or the solicitation of an offer to buy any securities, nor a solicitation of consents from any holders of securities, nor shall there be any sale of securities or solicitation of consents in any jurisdiction in which such offer, solicitation or sale would be unlawful prior to the registration or qualification under the securities laws of any such jurisdiction.
FORWARD-LOOKING STATEMENTS
Statements in this press release contain forward-looking statements. You can identify these forward-looking statements by use of words such as "strategy," "expects," "continues," "plans," "anticipates," "believes," "will," "estimates," "intends," "projects," "goals," "targets," "could," "should," and other words of similar meaning. You can also identify them by the fact that they do not relate strictly to historical or current facts. These forward-looking statements are subject to certain risks and uncertainties that could cause actual results to differ materially from those discussed in such statements, including whether the conditions specified in the Transaction Support Agreement will be satisfied, whether the Notes Exchange Offer, the Pyxus Term Loan Exchange Offer, the Intabex Term Loan Exchange Offer and the Equity Offering will commence within the time periods anticipated or at all, and whether the transactions contemplated thereby will be completed within the time period anticipated or at all, and no assurance can be given that the results in any forward-looking statement will be achieved. Any forward-looking statement speaks only as of the date on which it is made, and the Company disclaims any obligation to subsequently revise any forward-looking statement to reflect events or circumstances after such date or to reflect the occurrence of anticipated or unanticipated events, except as required by law. The Company cannot guarantee that any forward-looking statement will be realized, although the Company believes it has been prudent in its plans and assumptions. Achievement of future results is subject to risks, uncertainties and inaccurate assumptions. Should known or unknown risks or uncertainties materialize, or should underlying assumptions prove inaccurate, actual results could vary materially from those anticipated, estimated or projected. You should bear this in mind as you consider forward-looking statements in this press release. Any forward-looking statement is qualified by reference to the following cautionary statements. These factors include the factors discussed under the heading "Risk Factors" in the Company's Form 10-K for the fiscal year ended March 31, 2026 and the Company's subsequently filed quarterly reports on Form 10-Q, which are incorporated by reference therein, and any other cautionary statements, written or oral, which may be made or referred to in connection with any such forward-looking statements.
View original content to download multimedia:https://www.prnewswire.com/news-releases/pyxus-announces-transaction-support-agreement-with-a-majority-of-creditors-for-exchange-transactions-and-equity-offering-302931348.html
SOURCE Pyxus International, Inc.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What would Pyxus's proposed debt exchanges and equity offering accomplish?
If completed in full, the exchanges would convert approximately $92 million into equity, repay $65 million from equity offering proceeds and extend maturities on approximately $300 million of remaining debt. The proposed private offering is for up to $85 million of common stock at $2.50 per share.
When does Pyxus expect to complete the debt exchanges?
Pyxus expects completion on or before December 15, 2026, unless extended by agreement with the requisite supporting holders. The company agreed to commence the notes exchange no later than ten days after the support agreement's effective date, with the loan exchanges and equity offering to follow as promptly as reasonably practicable.
How does early participation affect consideration in the Pyxus debt exchanges?
Holders participating within ten business days after launch receive the full stated consideration; later participants receive 95%. Per $1,000 principal, later notes and Pyxus loan participants receive $327.15 in stock value and $642.11 in new notes. Later Intabex participants receive $645.44 in new notes and $327.15 in cash.
What would happen to existing Pyxus debt protections under the proposed consent solicitations?
The proposed amendments would remove most restrictive covenants and certain affirmative covenants and subordinate existing debt to the new exchange notes. For existing notes, they would also eliminate the change-of-control repurchase obligation, eliminate certain default provisions and release all collateral. The loan amendments would waive or eliminate certain defaults and events of default, if any.
Who can participate in the Pyxus private equity offering?
Qualified holders of existing notes, Pyxus term loans and Intabex term loans would be offered participation following commencement of the exchanges. Of the offering, $42.5 million is reserved for direct purchase by backstop parties. The remaining $42.5 million would be allocated pro rata among eligible participants, with $37.5 million backstopped.